SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chan, T Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, T Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ingestion of medicated oils by adults: the risk of severe salicylate poisoning is related to the packaging of these products

T YK Chan

Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China; tykchan{at}cuhk.edu.hk

Ingestion of medicated oils containing methyl salicylate poses the threat of severe, rapid-onset salicylate poisoning. In this retrospective study of 24 adults who had ingested ‘White Flower Oil’ (n=18) or ‘Red Flower Oil’ (n=6), the main objective was to determine if the risk of severe salicylate poisoning was related to the product packaging. ‘Red Flower Oil’ had a large bottle opening so that its content could be emptied much more easily. It also had a larger bottle size and usually had a higher methyl salicylate concentration than ‘White Flower Oil’. Patients tended to ingest a greater amount of ‘Red Flower Oil’ than ‘White Flower Oil’. Five per cent of subjects who had taken ‘White Flower Oil’, but 67% of subjects who had taken ‘Red Flower Oil’, had admission plasma salicy-late level ≥2.2 mmol/L (P=0.006). None of the subjects who had ingested ‘White Flower Oil’, but 50% of subjects who had taken ‘Red Flower Oil’, had moderate to severe symptoms (P=0.010). As a result, none of the subjects who had ingested ‘White Flower Oil’, but 33% of subjects who had taken ‘Red Flower Oil’, required urine alkalinization (P=0.054). One patient who had taken ‘Red Flower Oil’ died because of hospital-acquired pneumonia. All other patients made a complete recovery. To reduce the amount of methyl salicylate that can be readily swallowed during accidental or deliberate ingestion of medicated oils, improvements are needed in the existing packaging of these products.

Key Words: drug packaging • medicated oils • methyl salicylate

Human & Experimental Toxicology, Vol. 21, No. 4, 171-174 (2002)
DOI: 10.1191/0960327102ht240oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement